US Representative

Ann Wagner Authored & Sponsored Legislation

Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2574

Introduced
4/1/25  
No Iranian Energy Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2575

Introduced
4/1/25  
To provide for the rescission of certain waivers and licenses relating to Iran, and for other purposes.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2666

Introduced
4/7/25  
CBO Scoring Accountability Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB27

Introduced
1/3/25  
Refer
1/3/25  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl ActThis bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).Additionally, the bill establishes a new, alternative registration process for certain schedule I research.The bill also makes several other changes to registration requirements for conducting research with controlled substances, includingpermitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2702

Introduced
4/8/25  
Refer
4/8/25  
FIRM Act Financial Integrity and Regulation Management Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2729

Introduced
4/8/25  
Carnivals are Real Entertainment Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2777

Introduced
4/9/25  
S-CAP Act of 2025 S-Corporation Additional Participation Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2796

Introduced
4/9/25  
Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2911

Introduced
4/14/25  
Accounting STEM Pursuit Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2961

Introduced
4/17/25  
Frederick Douglass Trafficking Victims Prevention and Protection Reauthorization Act of 2025